Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up

References

• BRIQUETTE, D. J., MACKENZIE, P. I., VERONEZE, M. E. and MINERS, J. G., 1993, In vitro approaches can predict human drug metabolism. Trends in Pharmacological Sciences, 14, 292–294.
   PubMedGoogle Scholar
• BOURRIE, M., MEUNIER, V., BERGER, Y. and FABRE, G., 1996, Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalysed by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 277, 321–332.
   PubMed Web of Science ®Google Scholar
• BURKE, M. D., THOMPSON, S., ELCOMBE, C. R., HALPERT, J., HAAPARANTA, T. and MAYER, R. T., 1985, Ethoxy-, pentoxy-, and benzoyloxy-phenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology, 34, 3337–3345.
   PubMed Web of Science ®Google Scholar
• BUTLER, M. A., IWASAKI, M., GUENGERICH, F. P. and KADLUBAR F. F., 1989, Human cytochrome P-450PA (P-450IA2), the phenacetin 0-deethylase, is primarily responsible for the hepatic 3- demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA, 86, 7696–7700.
   Google Scholar
• COMBALBERT, J., FABRE, I., FABRE, G., DALET, C., DERANCOURT, J., CANO, J. P. and MAUREL, P., 1989, Metabolism of cyclosporin A: IV. Purification and identification of the rifampicin-inducible human liver cytochrome (cyclosporin A oxidase) as a product of P-45011IA gene subfamily. Drug Metabolism and Disposition, 17, 197–207.
   PubMed Web of Science ®Google Scholar
• CREAVEN, P. J., PARKE, D. V. and WILLIAMS, R. T., 1965, A spectrofluorimetric study of the 7-hydroxylation of coumarin by liver microsomes. Biochemical Journal, 96, 390–398.
   PubMed Web of Science ®Google Scholar
• DAUJAT, M., FABRE, I., DIAZ, D., PICHARD, L., FABRE, G,. FABRE, J. M., SAINT-AUBERT, B. and MAUREL, P., 1990, Inducibility and expression of class IA and IIIA cytochromes P450 in primary cultures of adult human hepatocytes. Biochemical Pharmacology (Life Sciences Advances), 9, 315–326.
   Google Scholar
• DAUJAT, M., PICHARD, L., DALET, C., LARROQUE, C., BONFILS, C., POMPON, D., LI, D., GUZELIAN, P. S. and MAUREL, P., 1987, Expression of five forms of microsomal cytochrome P-450 in primary cultures of rabbit hepatocytes treated with various classes of inducers. Biochemical Pharmacology, 36,3597–3607.
   PubMedGoogle Scholar
• DAUJAT, M., PICHARD, L., FABRE, I., PINEAU, T., FABRE, G., BONFILS, C. and MAUREL, P., 1991, Induction protocols for cytochrome P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods in Enzymology, 206,345–353.
   PubMed Web of Science ®Google Scholar
• DIAZ, D., FABRE, I., DAUJAT, M., SAINT AUBERT, P., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human cytochrome P450. Gastroenterology, 99, 737–747.
   PubMed Web of Science ®Google Scholar
• DONATO, M. T., CASTELL, J. V. and GOMEZ-LECHON, M. J., 1995, Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metabolism and Disposition, 23, 553–558.
   Google Scholar
• EKINS, S., WILLIAMS, J. A., MURRAY, G. I., BURKE, M. D., MARCHANT, N. C., ENGESET, J. and HAWKSWORTH, G. M., 1996, Xenobiotic metabolism in rat, dog and human precision-cut liver slices, freshly isolated hepatocytes and vitrified precision-cut liver slices. Drug Metabolism and Disposition, 24, 990–995.
   PubMed Web of Science ®Google Scholar
• FABRE, G., Boumuk, M., MARTI, E., FABRE, I., ROQUE, C., SAINT-AUBERT, B., JoYEux, H., MAUREL, P., BERGER, Y. and CANO, J. P., 1990, Inducibility of both cytochrome P-450 and UDP-glucuronosyl transfera isozymes in primary cultures of human hepatocytes. Biochemical Pharmacology (Life Sciences Advances), 9, 79–91.
   Google Scholar
• FABRE, G., CREVAT-PIZANO, P., DRAGNA, S., COVO, J., BARRA, Y. and CANO, J. P., 1988b, Involvement of the macrolide antibiotic cytochrome P450-LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver. Biochemical Pharmacology, 37, 1947–1953.
   PubMedGoogle Scholar
• FABRE, G., RAHMANI, R., PLACIDI, M., COMBALBERT, J., Covo, J., CANO, J. P., COULANGE, C., DUCROS, M. and RAMPAL, M., 1988a, Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human livers. Biochemical Pharmacology, 37, 4389–4397.
   PubMed Web of Science ®Google Scholar
• GED, C., ROUILLON, J. M., PICHARD, L., COMBALBERT, J., BRESSOT, N., BORIES, P., MICHEL, H., BEAUNE, P. and MAUREL, P., 1989, The increase in urinary excretion of 6/4-hydroxycortisol as a marker of human hepatic cytochrome P45011IA induction. British Journal of Clinical Pharmacology, 28, 373–387.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON, M. J., LOPEZ, P., DONATO, T., MONTOYA, A., LARRAURI, P., GIMENEZ, P., TRULLENQUE, R., FABRA, R. and CASTELL, J. V., 1990, Culture of human hepatocytes from small surgical liver biopsies: biochemical characterization and comparison with in vivo. In Vitro Cell Development in Biology, 26,67–74.
   Google Scholar
• GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMERS, P., WOLFF, T. and WAXMAN, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype of genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry, 261,5051–5060.
   PubMed Web of Science ®Google Scholar
• GUL,Louzo, A., 1997, Biotransformation of drugs by hepatocytes. In In Vitro Methods in Pharmaceutical Research (Orlando: Academic Press), pp. 411–429.
   Google Scholar
• Isom, H. C. and GEORGOFF, I., 1984, Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in a chemically-defined medium. Proceedings of the National Academy of Sciences, USA, 81, 6378–6382.
   PubMedGoogle Scholar
• IWATSUBO, T., HIROTA, N., OOIE, T., SUZUKI, H., SHIMADA, N., CHIBA, K., ISHIZAKI, T., GREEN, C. E., TYSON, C. A. and SUGIYAMA, Y., 1997, Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacology and Therapeutics, 73, 147–171.
   PubMed Web of Science ®Google Scholar
• KOCAREK, T. A., SCHUETZ, E. G., STROM, S. C., FISHER, R. A. and GUZELIAN, P. S., 1995, Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition, 23, 415–421.
   PubMed Web of Science ®Google Scholar
• LI, A. P., 1997, Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug—drug interactions. In Advances in Pharmacology, vol. 43 (Orlando: Academic Press), pp. 103–130.
   Google Scholar
• Li, A. P., RASMUSSEN, A., Xu, L. and KAMINSKI, D. L., 1995, Rifampicin induction of lidocaine metabolism in cultured human hepatocytes. Journal of Pharmacology and Experimental Therapeutics, 274, 673–677.
   PubMed Web of Science ®Google Scholar
• MAURICE, M., PICHARD, L., DAUJAT, M., FABRE, I., JoyEux, H., DOMERGUE, J. and MAUREL, P., 1992, Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB Journal, 6,752–758.
   PubMed Web of Science ®Google Scholar
• MCKINNON, R. A., HALL, P. M., QUATTROCHI, L., TUKEY, R. H. and McMANus, M. E., 1991, Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepato cellular carcinoma by in situ hybridization. Hepatology, 14, 848–852.
   PubMed Web of Science ®Google Scholar
• MINERS, M. O. VERONESE, M. E. and BIRKETT, D. J., 1994, In vitro approaches for the prediction of human drug metabolism. In J. A. Bristol (ed.), Annual Reports in Medicinal Chemistry, vol. 29 (Orlando: Academic Press), pp. 306–316.
   Google Scholar
• NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREIZEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biology, 12, 1–51.
   PubMed Web of Science ®Google Scholar
• OLINGA, P., MEREMA, M., HOF, I. H., DE JONG, K. P., SLOOFF, M. J. H., MEIJER, D. K. F. and GROOTHUIS, G. M. M., 1998, Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metabolism and Disposition, 26, 5–11.
   Google Scholar
• PELKONEN, O., SOTANIEMI, E. A. and AHOKAS, J. T., 1985, Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and inter-species comparison. British Journal of Clinical Pharmacology, 19, 59–66.
   PubMed Web of Science ®Google Scholar
• PICHARD, P., FABRE, I., FABRE, G., DOMERGUE, J., SAINT AUBERT, B., MOURAD, G. and MAUREL P., 1990, Cyclosporin A drug interactions: screening for inducers and inhibitors of cytochrome P450 (cyclosporin A oxidase) in primary cultures of human hepatocytes. Drug Metabolism and Disposition, 18, 595–606.
   Google Scholar
• POLLARD, H. B., MENARD, R., BRANDT, H. A., PAZOLES, C. J., CREUTZ, C. E. and RAMU, A., 1978, Application of Bradford's protein assay to adrenal gland subcellular fractions. Analytical Biochemistry, 86,761–763.
   PubMed Web of Science ®Google Scholar
• RODRIGUES, A. D., 1994, Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochemical Pharmacology, 48, 2147–2156.
   PubMed Web of Science ®Google Scholar
• SESARDIC, D., BOOBIS, A. R., EDWARDS, R. J. and DAVIES, D. S., 1988, A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. British Journal of Clinical Pharmacology, 26, 363–372.
   PubMed Web of Science ®Google Scholar
• SILVA, J. M., MORIN, P. E., DAY, S. H., KENNEDY, P. P., RUSHMORE, T., YERGEY, J. A. and NICOLL-GRIFFITH, D. A., 1998, Refinement of an in vitro cell model for cytochrome P450 induction. Drug Metabolism and Disposition, 26,490–496.
   Google Scholar
• SHIMADA, T., YAMAZAKI, H., MINURA, M., INUI, Y. and GUENGERICH F. P., 1994, Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals; studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   Google Scholar
• TUCKER, G. T., 1992, The rational selection of drug interaction studies; Implications of recent advances in drug metabolism. Internationd Journal of Clinical Pharmacology, Therapeutics and Toxicology, 30, 550–553.
   PubMed Web of Science ®Google Scholar
• WADHWA, N. K., SCHROEDER, T. J., PESCE, A. J., MYRE, S. A., CLARDY, C. W. and FIRST, M. R., 1987, Cyclosporin drug interactions: a review. Therapeutics and Drug Monitoring, 9, 399–406.
   PubMed Web of Science ®Google Scholar
• WATKINS, P. B., MURRAY, S. A., WINKELMAN, L. G., HEUMAN, D. M., WRIGHTON, S. A. and GUZELIAN, P. S., 1989, Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Journal of Clinical Investigation, 83, 688–697.
   PubMed Web of Science ®Google Scholar
• WATKINS, P. B., WRIGHTON, S. A., MAUREL, P., SCHUETZ, E. G., MENDEZ-PICON, G., PARKER, G. A. and GUZELIAN, P. S., 1985, Identification of an inducible form of cytochrome P-450 in human liver. Proceedings of the National Academy of Sciences, USA, 82, 6310–6314.
   Google Scholar
• WRIGHTON, S. A. and STEVENS, J. C., 1992, The human hepatic cytochromes P450 involved in drug metabolism. Critical Review in Toxicology, 22,1–21.
   PubMed Web of Science ®Google Scholar